Magnus Financial Group LLC Has $275,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Magnus Financial Group LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 816 shares of the medical equipment provider’s stock after selling 42 shares during the quarter. Magnus Financial Group LLC’s holdings in Intuitive Surgical were worth $275,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. OFI Invest Asset Management purchased a new stake in shares of Intuitive Surgical in the third quarter worth approximately $25,000. Baystate Wealth Management LLC grew its holdings in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 45 shares in the last quarter. MCF Advisors LLC raised its position in Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 40 shares during the last quarter. Headinvest LLC purchased a new position in Intuitive Surgical during the 3rd quarter worth $28,000. Finally, Stone House Investment Management LLC grew its stake in shares of Intuitive Surgical by 100.0% in the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other news, President David J. Rosa sold 80,710 shares of the firm’s stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $389.28, for a total value of $31,418,788.80. Following the completion of the transaction, the president now directly owns 163,399 shares in the company, valued at $63,607,962.72. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, President David J. Rosa sold 80,710 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The stock was sold at an average price of $389.28, for a total transaction of $31,418,788.80. Following the completion of the sale, the president now directly owns 163,399 shares in the company, valued at $63,607,962.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 20,296 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $393.80, for a total value of $7,992,564.80. Following the completion of the transaction, the executive vice president now owns 5,507 shares in the company, valued at approximately $2,168,656.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 225,093 shares of company stock valued at $87,153,299. Corporate insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 8th. BTIG Research boosted their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Robert W. Baird reduced their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a report on Friday, April 19th. Truist Financial lifted their price target on Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. Finally, Piper Sandler upped their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $396.17.

Intuitive Surgical Stock Down 0.3 %

ISRG opened at $374.14 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The firm has a 50-day simple moving average of $386.10 and a two-hundred day simple moving average of $347.50. The company has a market capitalization of $132.71 billion, a PE ratio of 67.53, a price-to-earnings-growth ratio of 4.85 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the company posted $1.00 EPS. Intuitive Surgical’s quarterly revenue was up 11.5% on a year-over-year basis. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.